Updated BIOSECURE Act draft clears House committee
4 days ago · House Oversight Committee passes BIOSECURE Act, which would restrict US companies from contracting with Chinese biotechs, including WuXi AppTec, MGI, and BGI.
Anti-China BIOSECURE Act dealt blow, left out of defense bill - STAT
Dec 8, 2024 · WASHINGTON — Legislation to restrict U.S. drugmakers from using key Chinese contract manufacturers was dealt a major blow when senators left it out of a must-pass …
Relief for Chinese biotechs as BIOSECURE Act delayed
Dec 9, 2024 · The BIOSECURE Act, which will prohibit businesses in the US from contracting with various Chinese firms on national security grounds, has not been included in a defence budget …
BIOSECURE Act: Industry Closely Following in the Lame Duck
Nov 20, 2024 · As Congress returns for the lame duck session, the life sciences industry is closely watching the fate of the BIOSECURE Act, which would limit the ability of U.S. life sciences …
Reprieve for Chinese biotechs as BIOSECURE Act left out of key bill
Dec 9, 2024 · The omission means the act, which intends to prevent Chinese biotechs and manufacturers from accessing US funding and collaborating with US pharma companies using …
BIOSECURE Act Sails Through House Passage, Lines Up Senate Vote
Sep 10, 2024 · The U.S. House of Representatives on Monday voted in favor of the BIOSECURE Act, which would restrict American companies from working with specific Chinese biotech …
Biosecure Act Out of Key Defense Bill in Win for Chinese Biotech
Dec 8, 2024 · Five Chinese-linked biotechnology firms won a reprieve Saturday when negotiators on a key defense bill decided not to include legislation blacklisting the companies from new …
U.S. House Passes BIOSECURE Act to Limit Foreign Biotech Influenc
Sep 16, 2024 · The U.S. House approved the BIOSECURE Act, restricting federal funds for biotech companies tied to foreign adversaries. Now moving on to the Senate.
New bill sets decoupling deadline for industry's work with WuXi
May 10, 2024 · Right after an industry survey suggested that switching away from Chinese CDMOs could take biopharma companies up to eight years, lawmakers have adjusted the …
Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act
Sep 9, 2024 · The bipartisan, bicameral bill prohibits U.S. taxpayer dollars from flowing to biotechnology companies that are owned, operated, or controlled by China or other foreign …